
Rite Aid Corporation RAD
Quarterly report 2024-Q2
added 05-16-2026
Rite Aid Corporation Interest Expense 2011-2026 | RAD
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Rite Aid Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 224 M | 192 M | 201 M | 230 M | 57.9 M | 56 M | 50.3 M | 50.3 M | 41 M | 97.4 M | 103 M | 128 M | 130 M | 134 M | 478 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 478 M | 41 M | 145 M |
Quarterly Interest Expense Rite Aid Corporation
| 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72.7 M | 65.2 M | 57.4 M | 52.5 M | 48.1 M | 57.4 M | 47.8 M | 48.6 M | 49.1 M | 47.8 M | 50.8 M | 50 M | 50.5 M | 50.8 M | 57.9 M | 60.1 M | 58.3 M | 57.9 M | 56 M | 56.2 M | 62.8 M | 56 M | 50.3 M | 111 M | 110 M | 50.3 M | 106 M | 105 M | 105 M | 50.3 M | 107 M | 115 M | 124 M | 41 M | 97.4 M | 101 M | 101 M | 97.4 M | 97.4 M | 101 M | 101 M | 103 M | 103 M | 107 M | 113 M | 128 M | 128 M | 129 M | 131 M | 130 M | 130 M | 131 M | 131 M | 134 M | 140 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 140 M | 41 M | 85.9 M |
Interest Expense of other stocks in the Pharmaceutical retailers industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BOQI International Medical
BIMI
|
170 K | - | 6.33 % | $ 5.86 M | ||
|
Greenlane Holdings
GNLN
|
213 K | $ 3.06 | -6.85 % | $ 22.9 M | ||
|
PetMed Express
PETS
|
758 K | $ 2.12 | -2.3 % | $ 43.7 M | ||
|
Trxade Group
MEDS
|
1.2 M | - | 4.55 % | $ 5.8 M | ||
|
Walgreens Boots Alliance
WBA
|
482 M | - | - | $ 10.3 B | ||
|
111
YI
|
-595 K | $ 5.7 | 1.42 % | $ 979 M | ||
|
LifeMD
LFMD
|
1.36 M | $ 4.19 | 2.95 % | $ 189 M |